Coronary Syndrome: Clinical Trials

29 trials for Coronary Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 8 unknown, 4 active not recruiting, 2 recruiting. 8 Not applicable, 2 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 6, Active not recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1
Phase 31Recruiting 1
Phase 41Completed 1

Follow Coronary Syndrome: new trials by email Literature Review of Coronary Syndrome trials Research Report on Coronary Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Conventional and Non-Conventional CRF and Their Association With Acute Coronary Syndrome
Conventional Risk Factor Assessment, Non-Conventional Risk Factor - Coronary Syndrome
Active not recruitingSuperior University2222025-03-172025-07-03
A MAajor RAdiation-based PCI Study in STEMI and NSTEMI
Non Complex PCI, Complex PCI - Myocardial Infarction (MI), Radiation Toxicity
Active not recruitingCentre Cardiologique du Nord156302025-03-012026-08-21
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
Acute Coronary Syndrome, STEMI
Active not recruitingPowerful Medical8002024-12-102026-03-20
Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas
Cardiovascular Abnormalities, Arterial Blood Pressure
Enrolling by invitationLaikο General Hospital, Athens502024-02-052026-01-05
Implementation of Contemporary Coronary CT Angiography in Clinical Practice
Coronary Artery Disease of Significant Bypass Graft, Coronary Syndrome
UnknownHumanitas Hospital, Italy10002023-10-102024-03-01
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg - Stroke, Stroke, Ischemic
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris28002023-05-172025-09-08
Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
blood sample collection - Coronary Syndrome
UnknownIstituto Nazionale di Ricovero e Cura per Anziani202023-03-062024-03-05
Body Composition Estimated by Bioelectrical Impedance Analysis in Patients with Acute Coronary Syndrome.
Coronary Syndrome, Obesity
UnknownHospital de Clinicas José de San Martín1002023-02-112024-08-20
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina
CryoTherapy System (CTS) - Coronary Artery Disease, Coronary Syndrome
Not applicableActive not recruitingCryotherapeutics SA302022-05-182026-03-24
Use of Various Configurations of Different Arterial Grafts in Total Arterial Revascularization
coronary artery bypass grafting surgery - Coronary Syndrome, Coronary Disease
UnknownAssiut University502022-03-222022-03-29
WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?
Aspirin 75mg, Aspirin 20mg, Rivaroxaban 2.5 mg - Coronary Syndrome
Phase 4CompletedSheffield Teaching Hospitals NHS Foundation Trust482021-08-262026-02-20
5 Years Follow up of the SAPIEN 3 Valve From the DIRECTAVI Trial
Transcatheter heart valve implantation with or withour predilatatation - Coronary Syndrome, Hemodynamic Instability
CompletedUniversity Hospital, Montpellier2362021-05-012024-01-17
RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
blood draws - Coronary Syndrome
RecruitingIRCCS Policlinico S. Donato702020-07-132023-10-06
Multi-omics Study of Young Adults Coronary Syndrome Patients
Coronary Syndrome
UnknownShenzhen People's Hospital2002020-07-012021-04-28
Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area
Coronary Syndrome
CompletedUniversity Hospital, Montpellier3022020-06-012021-05-11
Power Walking in Cardiac Patients Who Underwent Post-coronary Angioplasty
Power walking, Standardised outpatient cardiac rehabilitation - Heart Diseases, Ischemic, Coronary Artery Disease
Not applicableCompletedGulf Medical University242020-04-072022-10-18
Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19
Tele-medicine platform - Angina Pectoris, Acute Coronary Syndrome
Not applicableUnknownProfessor Adrian Covic2002020-03-312020-04-01
Cerebral Oxygenation and Burst Suppression
Coronary Syndrome, Pediatric
CompletedGöteborg University152020-01-202025-09-09
The Randomized OPTIMAL-ACT Trial
Unfractionated heparin - Coronary Artery Disease, Ischemic Heart Disease
Phase 2CompletedMayo Clinic1802019-02-082023-04-04
STEMI and Incretins Treatment
PCI and DES stenting, Incretins - STEMI, Coronary Artery Disease
CompletedUniversity of Campania Luigi Vanvitelli9002017-01-012017-10-19

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Angina, Unstable (29)  ·  Coronary Artery Disease (9)  ·  Coronary Disease (5)  ·  Acute Coronary Syndrome (4)  ·  Myocardial Infarction (4)  ·  Anxiety Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Coronary Occlusion (2)  ·  Diabetes Mellitus (2)  ·  Myocardial Ischemia (2)  ·  ST Elevation Myocardial Infarction (2)  ·  Angina Pectoris (1)  ·  Angina, Stable (1)  ·  Atherosclerosis (1)  ·  COVID-19 (1)

Broader conditions

Chest Pain (29)  ·  Neurologic Manifestations (29)  ·  Pain (29)  ·  Pathological Conditions, Signs and Symptoms (29)  ·  Signs and Symptoms (29)  ·  Vascular Diseases (29)  ·  Angina Pectoris (28)  ·  Heart Diseases (28)  ·  Cardiovascular Diseases (27)  ·  Myocardial Ischemia (27)  ·  Arterial Occlusive Diseases (10)  ·  Arteriosclerosis (10)  ·  Coronary Disease (7)  ·  Pathologic Processes (6)  ·  Infarction (5)

Interventions

Aspirin (2)  ·  Blood Specimen Collection (1)  ·  Colchicine (1)  ·  Heparin (1)  ·  Incretins (1)  ·  Percutaneous Coronary Intervention (1)  ·  Rivaroxaban (1)  ·  Rosuvastatin Calcium (1)  ·  Ticagrelor (1)  ·  olmesartan (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  University Hospital, Montpellier (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Assiut University (1)  ·  Centre Cardiologique du Nord (1)  ·  Cryotherapeutics SA (1)  ·  Elpen Pharmaceutical Co. Inc. (1)  ·  Federal University of São Paulo (1)  ·  Gulf Medical University (1)  ·  Göteborg University (1)  ·  Hospital de Clinicas José de San Martín (1)  ·  Humanitas Hospital, Italy (1)  ·  IRCCS Policlinico S. Donato (1)  ·  Istituto Nazionale di Ricovero e Cura per Anziani (1)  ·  Laikο General Hospital, Athens (1)

Countries

France (7)  ·  Italy (5)  ·  Greece (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  Georgia (1)  ·  Germany (1)  ·  Lithuania (1)  ·  Pakistan (1)  ·  Romania (1)  ·  South Korea (1)  ·  Sweden (1)

Top investigators

Florence Leclercq, PU PH (2)  ·  Alexandru Burlacu, MD, PhD (1)  ·  Carlo Andrea Pivato, MD (1)  ·  Cristina Plesoianu, PhD (1)  ·  Emanuele Barbato, MD, PhD (1)  ·  Francesco Nappi, MD (1)  ·  Giulio Stefanini, MD, PhD (1)  ·  Hyeon-Cheol Gwon, PhD (1)  ·  Irakli Gogorishvili, MD (1)  ·  Jozef Bartunek, MD, PhD (1)  ·  Juliana de L Lopes, PhD (1)  ·  Katriona Brooksbank, PhD (1)  ·  Kumaraguruparan Gopal, Ph.D (1)

Results publications

PMID 26589710, PMID 28979897, PMID 29103665, PMID 29980052, PMID 30266608, PMID 31972008, PMID 33032237, PMID 33580772, PMID 33838040, PMID 35862141, PMID 36074457, PMID 38253304, PMID 38926753, PMID 40512691